Reproductive infectious diseases (RID) represent a critical yet often-neglected intersection of public health, clinical care, and health equity. RID encompasses sexually transmitted infections (STIs), bacterial vaginosis (BV), and the host of reproductive sequelae and burden on reproductive-aged women worldwide, particularly in low-and middle-income countries where access to prevention, screening, and treatment remains limited. In 2020, the World Health Organization (WHO) estimated 374 million new infections globally with four curable STIs: chlamydia (129 million), gonorrhea (82 million), syphilis (7.1 million), and trichomoniasis (156 million).
